Matthew R. Kwietniak is CCO at Avid Bioservices, Inc. (CDMO). They have made 14 open-market trades across 1 company since 2023, most recently 2025-02-05.
CIK 0001974519
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CDMO | 50,796 | $634K |
Shares reported on the most recent Form 4, priced at the 2024-12-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDMO | SELL | 2024-12-26 | 2024-12-27 | $12.22 | $288K | +1.0% | +1.3% | N/A |
| CDMO | SELL | 2024-10-14 | 2024-10-15 | $10.15 | $1K | -3.8% | +14.8% | +19.6% |
| CDMO | SELL | 2024-10-10 | 2024-10-11 | $10.05 | $10K | +2.1% | +20.7% | +22.3% |
| CDMO | SELL | 2024-07-15 | 2024-07-16 | $8.36 | $3K | +7.7% | +12.4% | +6.6% |
| CDMO | SELL | 2024-07-12 | 2024-07-15 | $8.05 | $958 | +22.6% | +24.9% | +20.3% |
| CDMO | SELL | 2024-07-10 | 2024-07-11 | $7.54 | $3K | +16.1% | +31.6% | +28.7% |
| CDMO | SELL | 2024-04-30 | 2024-05-02 | $7.40 | $9K | +10.7% | -4.1% | +25.6% |
| CDMO | SELL | 2024-01-12 | 2024-01-12 | $6.77 | $2K | +12.2% | +19.8% | +11.8% |
| CDMO | SELL | 2024-01-10 | 2024-01-11 | $6.17 | $7K | -2.5% | +9.2% | +1.9% |
| CDMO | SELL | 2023-10-12 | 2023-10-13 | $9.19 | $2K | -19.4% | -39.0% | -17.9% |
| CDMO | SELL | 2023-10-10 | 2023-10-11 | $9.20 | $9K | -22.7% | -44.6% | -31.6% |
| CDMO | SELL | 2023-07-12 | 2023-07-13 | $13.61 | $3K | -1.2% | -4.5% | -30.5% |
| CDMO | SELL | 2023-07-10 | 2023-07-11 | $13.77 | $7K | +2.2% | -5.7% | -30.7% |
| CDMO | SELL | 2023-06-29 | 2023-06-30 | $12.70 | $100K | -2.6% | -7.8% | -29.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.